Search
Atypical chemokine receptor 1
go.drugbank.com/bio_entities/BE0015068TargetHumansAtypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead … Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor.
Polypeptides: Atypical chemokine receptor 1Synonyms: Plasmodium vivax receptor, Duffy antigen/chemokine receptorInterferon lambda receptor 1
go.drugbank.com/bio_entities/BE0016547TargetHumansThe IFNLR1/IL10RB dimer is a receptor for the cytokine ligands IFNL2 and IFNL3 and mediates their antiviral activity. … Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense.
Polypeptides: Interferon lambda receptor 1Synonyms: IFN-lambda receptor 1, IL-28 receptor subunit alphaInterleukin-17 receptor D
go.drugbank.com/bio_entities/BE0017358TargetHumansFeedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation (PubMed:12807873, PubMed:12958313). Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK wi...
Polypeptides: Interleukin-17 receptor DSynonyms: IL-17 receptor D, Interleukin-17 receptor-like proteinLysophosphatidic acid receptor 1
go.drugbank.com/bio_entities/BE0017535TargetHumansReceptor for lysophosphatidic acid (LPA) (PubMed:19306925, PubMed:25025571, PubMed:26091040, PubMed:9070858). … Activates downstream signaling cascades via the G(i)/G(o), G(12)/G(13), and G(q) families of heteromeric G proteins.
Polypeptides: Lysophosphatidic acid receptor 1Synonyms: LPA receptor 1, Lysophosphatidic acid receptor Edg-2Interleukin-17 receptor A
go.drugbank.com/bio_entities/BE0018249TargetHumansReceptor for IL17A (PubMed:17911633, PubMed:9367539). Receptor for IL17F (PubMed:17911633, PubMed:19838198). Binds to IL17A with higher affinity than to IL17F (PubMed:17911633). … Receptor for IL17C as part of a heterodimeric complex with IL17RE (PubMed:21993848)
Polypeptides: Interleukin-17 receptor ASynonyms: IL-17 receptor AInterleukin-17 receptor B
go.drugbank.com/bio_entities/BE0020027TargetHumansReceptor for the pro-inflammatory cytokines IL17B and IL17E. May play a role in controlling the growth and/or differentiation of hematopoietic cells
Polypeptides: Interleukin-17 receptor BSynonyms: IL-17 receptor B, IL-17B receptorInsulin receptor substrate 2
go.drugbank.com/bio_entities/BE0021286TargetHumansSignaling adapter protein that participates in the signal transduction from two prominent receptor tyrosine kinases, insulin receptor/INSR and insulin-like growth factor I receptor/IGF1R (PubMed:25879670 … Upon phosphorylation by the insulin receptor, functions as a signaling scaffold that propagates insulin action through binding to SH2 domain-containing proteins including the p85 regulatory subunit of
Polypeptides: Insulin receptor substrate 2Ethinylestradiol
go.drugbank.com/drugs/DB00977ApprovedInvestigationalEthinylestradiol was first synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering. It was developed in an effort to create an estrogen with greater oral bioavailability. These properties were achieved by the substitu...
Mixtures: PIL KB HARMONIS, PIL KB I KOMBINASIProducts: NAVEENTeglarinad chloride
go.drugbank.com/drugs/DB05217InvestigationalAlthough the exact mechanism of action has yet to be fully elucidated, GMX1778 appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis.
Telmisartan
go.drugbank.com/drugs/DB00966ApprovedInvestigational[A1489,A1490] Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.[A1492] … Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.
Categories: Angiotensin 2 Receptor Blocker, Angiotensin II receptor antagonists